LifeScan gets the green-light from the FDA for its blood glucose monitoring system that uses Bluetooth technology to wirelessly communicate with iPhone and iPad devices.
LifeScan, has received regulatory clearance from the FDA for its OneTouch VerioSync blood glucose monitoring system, the first monitoring system to integrate with the Apple app store.
The app, called the OneTouch Reveal, is available on iPhone, iPad or iPod touch.
The system automatically sends blood glucose levels to mobile devices, displaying information in a 14-day summary with simple visual breakdowns. Patients can also share information via text or email or with their doctors or friends.
"For so many people, their iPhone, iPad or iPod touch have become a tool of choice to help organize and take charge of their daily lives," said Ty Lee, VP or marketing in a statement. "For people with diabetes, the new OneTouch® Verio®Sync System will enable them to use their iOS device to view and share their blood glucose results wirelessly, in much the same way they rely on them in other areas of their lives."
Back in September 2011, LifeScan teamed up with Cellnovo to develop its mobile diabetes care products.
Sales and profits were down during the 1st quarter for GE Healthcare, which cited "market volatility...
Vital Therapies once again lowers the bar on its initial public offering, pricing the flotation at $...
Here's a look at some of the top Wall Street stories for medical device companies this week.
A U.S. District Judge defends a ban on Medtronic's newly approved CoreValve transcatheter aortic...